Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...

詳細記述

書誌詳細
主要な著者: Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani
フォーマット: 論文
言語:English
出版事項: Elsevier 2022-01-01
シリーズ:Informatics in Medicine Unlocked
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2352914822000247